Found: 7
Select item for more details and to access through your institution.
Potential role of the ABCG2-Q141K polymorphism in type 2 diabetes.
- Published in:
- PLoS ONE, 2021, v. 16, n. 12, p. 1, doi. 10.1371/journal.pone.0260957
- By:
- Publication type:
- Article
The HSP co-inducer BGP-15 can prevent the metabolic side effects of the atypical antipsychotics.
- Published in:
- Cell Stress & Chaperones, 2012, v. 17, n. 4, p. 517, doi. 10.1007/s12192-012-0327-5
- By:
- Publication type:
- Article
Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies.
- Published in:
- Metabolic Syndrome & Related Disorders, 2014, v. 12, n. 2, p. 125, doi. 10.1089/met.2013.0098
- By:
- Publication type:
- Article
Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82417-8
- By:
- Publication type:
- Article
Génexpressziós eltérések keringő fehérvérsejtekben a 2-es típusú cukorbetegek elsőfokú, anyagcseréjüket illetően egészséges rokonaiban.
- Published in:
- Hungarian Medical Journal / Orvosi Hetilap, 2020, v. 161, n. 18, p. 738, doi. 10.1556/650.2020.31706
- By:
- Publication type:
- Article
Synergetic Insulin Sensitizing Effect of Rimonabant and BGP-15 in Zucker-Obes Rats.
- Published in:
- Pathology & Oncology Research, 2013, v. 19, n. 3, p. 571, doi. 10.1007/s12253-013-9620-6
- By:
- Publication type:
- Article
A Novel Insulin Sensitizer Drug Candidate-BGP-15-Can Prevent Metabolic Side Effects of Atypical Antipsychotics.
- Published in:
- Pathology & Oncology Research, 2012, v. 18, n. 4, p. 1071, doi. 10.1007/s12253-012-9546-4
- By:
- Publication type:
- Article